Pipeline

banner_std

Pipeline

ImmBALANCE® is being developed as a pharmaceutical product to reduce/prevent the allergic response in children, adolescents and adults.

The company’s first product will be for the treatment of paediatric allergy. Future clinical development programmes will be designed to show that ImmBALANCE® may be used prophylactically to reduce the incidence of childhood allergies, including atopic dermatitis, food allergies and allergic asthma.

Pipeline